Dr. Maria Elissa Torres, MD Psychiatry & Neurology - Psychosomatic Medicine Medicare: Accepting Medicare Assignments Practice Location: 2 Cindy Ln, Long Valley, NJ 07853 Phone: 908-745-1578 |
News Archive
Most successful vaccines and drugs rely on protecting humans or animals by blocking certain bacteria from growing in their systems.
ArQule, Inc. today announced the initiation of a Phase 2, single agent trial with ARQ 197 in gastric cancer by Kyowa Hakko Kirin, its exclusive licensee for the development and commercialization of ARQ 197 in the Asian territory consisting of Japan, China (including Hong Kong), South Korea and Taiwan. Initiation of this trial will trigger a $5 million milestone payment to ArQule from Kyowa Hakko Kirin.
"Employers who offer health insurance coverage could see a 9 percent cost increase next year, and their workers may face an even bigger hit, according to a report Thursday from consulting firm PricewaterhouseCoopers," the Associated Press reports.
Tuberculosis is one of the world's most vexing public health problems. About 1.5 million people died from this bacterial lung infection in 2018, and the World Health Organization estimates that one-quarter of the world's population - some 2 billion people, mostly in developing countries - are infected with the bacteria that causes TB.
Women who receive an educational or nutritional intervention following the completion of their treatment for breast cancer are less likely to be depressed and have a better quality of life than other breast cancer survivors, according to a study by researchers at Carnegie Mellon University, the University of Pittsburgh Medical Center and Emory University.
› Verified 6 days ago